Literature DB >> 15760612

The underdiagnosis of the vascular contribution to dementia.

Amos D Korczyn1.   

Abstract

The existence of vascular dementia (VaD) was first identified by Marie, who described the etat lacunaire, and by Binswanger, who identified white matter lesions in the brain subcortical areas. Alois Alzheimer, when defining the disease now bearing his name, did so in a patient with a presenile onset. The majority of demented elderly people were then believed to have cerebral arteriosclerosis underlying their cognitive decline. The role of cortical vascular lesions, while clear to clinicians, was highlighted only later, by the pathological studies of Tomlinson et al. and the clinical demonstrations of Hachinski et al. who have defined multi-infarct dementia. Lately, the emphasis shifted to pathogenic mechanisms for vascular brain disease with the identification of a multitude of processes, such as lipohyalinosis, cardiac dysfunction and genetic causes, to name only a few. Epidemiologic studies have demonstrated the high frequency of vascular lesions in brains of demented individuals, as well as the fact that vascular factors can contribute to Alzheimer's disease (AD). Moreover, many factors, which were identified as contributing to cerebrovascular disease in general and VaD in particular, are frequently suspected as predisposing to AD as well. All these considerations converge to the realization that vascular components are extremely important in the pathogenesis of old-age dementia and that prevention and perhaps treatment of dementia are within reach. These surprising findings highlight the importance of mixed vascular-degenerative dementia as a disorder that has to be properly defined.

Entities:  

Mesh:

Year:  2005        PMID: 15760612     DOI: 10.1016/j.jns.2004.11.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Toward a pathological definition of vascular dementia.

Authors:  Lea Tenenholz Grinberg; Helmut Heinsen
Journal:  J Neurol Sci       Date:  2010-12-15       Impact factor: 3.181

2.  Dietary fat intake in relation to cognitive change in high-risk women with cardiovascular disease or vascular factors.

Authors:  M-N Vercambre; F Grodstein; J H Kang
Journal:  Eur J Clin Nutr       Date:  2010-07-21       Impact factor: 4.016

3.  Vascular Dementia.

Authors:  Alberto R Ramos; Salim I Dib; Clinton B Wright
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

4.  Cerebral embolism and Alzheimer's disease.

Authors:  Miia Kivipelto; Alina Solomon
Journal:  BMJ       Date:  2006-05-13

5.  Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.

Authors:  Fumiko Irie; Kamal H Masaki; Helen Petrovitch; Robert D Abbott; G Webster Ross; Dennis R Taaffe; Lenore J Launer; Lon R White
Journal:  Arch Gen Psychiatry       Date:  2008-08

6.  Association between sleep duration and the mini-mental score: the Northern Manhattan study.

Authors:  Alberto R Ramos; Chuanhui Dong; Mitchell S V Elkind; Bernadette Boden-Albala; Ralph L Sacco; Tatjana Rundek; Clinton B Wright
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

7.  Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.

Authors:  Christiane Reitz; Bindu Patel; Ming-Xin Tang; Jennifer Manly; Richard Mayeux; Jose A Luchsinger
Journal:  J Neurol Sci       Date:  2007-02-27       Impact factor: 3.181

8.  The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia.

Authors:  Marianna Trebunová; Eva Slabá; Viera Habalová; Zuzana Gdovinová
Journal:  J Neural Transm (Vienna)       Date:  2009-01-14       Impact factor: 3.575

9.  Contribution of vascular risk factors to the progression in Alzheimer disease.

Authors:  Elizabeth P Helzner; José A Luchsinger; Nikolaos Scarmeas; Stephanie Cosentino; Adam M Brickman; M Maria Glymour; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-03

Review 10.  The role of higher-level cognitive function in gait: executive dysfunction contributes to fall risk in Alzheimer's disease.

Authors:  Pamela L Sheridan; Jeffrey M Hausdorff
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.